Jump to content

Hang onto your hat: Sclero Forums Upgrade May 14-21, 2017!! The Forums will be offline for up to 4 days, and then will return with an entirely new look and feel.


Screening for pulmonary arterial hypertension in patients with systemic sclerosis.

  • Please log in to reply
3 replies to this topic

#1 Joelf


    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,905 posts
  • Location:West Sussex

Posted 25 July 2011 - 12:07 PM

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long-term survival.

Compared with routine clinical practice, PAH detection programs in SSc are able to identify patients with milder forms of the disease, allowing earlier management. Humbert M. (PubMed) Arthritis rheumatologist. 2011 Jul 18. (Also see: PAH)

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Jo Frowde
ISN Assistant Webmaster
SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager
ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)

#2 marsha


    Silver Member

  • Members
  • PipPipPipPip
  • 157 posts
  • Location:Maine

Posted 25 July 2011 - 12:12 PM

Just had this testing done Thursday.. :)

#3 Jeannie McClelland

Jeannie McClelland

    Senior Gold Member

  • ISN Support Specialists
  • PipPipPipPipPipPipPipPipPipPip
  • 1,696 posts
  • Location:in the Rocky Mountains of the USA

Posted 25 July 2011 - 12:24 PM

The part of the article I liked was the improvement in survival time! The patients found through screening (earlier diagnosis), the 'detected' group went from one-, 3-, 5-, and 8-year survival rates were 75%, 31%, 25%, and 17%, (not routinely screened without demonstrable clinical symptoms) respectively, to 100%, 81%, 73%, and 64% in detected by earlier screening patients. That's an enormous jump and all to our benefit. It was a small study with a limited number of patients, but wow, if this is demonstrated in greater numbers, it would be truly wonderful.
Jeannie McClelland
(Retired) ISN Director of Support Services
(Retired) ISN Sclero Forums Manager
(Retired) ISN Blog Manager
(Retired) ISN Assistant News Guide
(Retired) ISN Artist
International Scleroderma Network

#4 Sam


    Gold Member

  • Members
  • PipPipPipPipPipPip
  • 639 posts
  • Location:Delta, Ohio

Posted 29 July 2011 - 08:00 AM

I am in a study similar to this. This is my second year.